BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37315647)

  • 1. Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.)G.H.Sungetal against lung adenocarcinoma.
    Zhang X; Wang M; Liang X; Wang J; Zhang M; Li C; Wei L; Bi H
    J Ethnopharmacol; 2023 Dec; 317():116739. PubMed ID: 37315647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
    Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
    Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
    Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
    Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis.
    Yang FR; Li SY; Hu XW; Li XR; Li HJ
    Drug Des Devel Ther; 2022; 16():2365-2382. PubMed ID: 35910781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
    Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M
    BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
    Zhao XY; Yang YY; Feng JL; Feng CL
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering anti-influenza mechanism of Ophiocordyceps sinensis using network pharmacology, molecular pharmacology, and metabolomics.
    Zhou J; Wang M; Sun T; Zhou X; Wang J; Wang Y; Zhang R; Luo R; Yu H
    Medicine (Baltimore); 2023 Sep; 102(35):e34843. PubMed ID: 37657041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
    Wu Q; Wang YB; Che XW; Wang H; Wang W
    J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
    Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
    Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
    Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
    Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the mechanisms of action of
    Zhang X; Wang M; Qiao Y; Shan Z; Yang M; Li G; Xiao Y; Wei L; Bi H; Gao T
    Ann Transl Med; 2022 Mar; 10(6):282. PubMed ID: 35434037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
    Xu S; Liu R; Da Y
    Thorac Cancer; 2018 Aug; 9(8):974-988. PubMed ID: 29870138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
    Wang YC; Hui JR; Xiao G; Ma QL
    Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.